Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.

Autoimmunity reviews - 1 Sept 2009

Kong Yi-chi M, Jacob Jennifer B, Flynn Jeffrey C, Elliott Bruce E, Wei Wei-Zen

Abstract excerpt

Improving cancer immunotherapy by targeting T cell network also triggers autoimmunity. We disrupted regulatory T cell (Treg) function to probe the balance between breast cancer vaccination and autoimmune thyroiditis (EAT) in four models, with particular attention to MHC-associated susceptibility, EAT induction with mouse thyroglobulin (mTg) without adjuvant, and tolerance to Her-2/neu in transgenic mice. 1) In...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Breast Neoplasms
Share to Clinical Trials as Topic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genes, MHC Class II

Share to Immunotherapy

Share to Mice, Inbred CBA

Share to T-Lymphocytes

Share to Thyroglobulin

Share to Thyroiditis, Autoimmune

Source

Open in PubMed Open full text

Identifiers

PMID: 19254781
DOI: 10.1016/j.autrev.2009.02.034
PMCID: PMC2762207

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.PMID 19254781Read ↗

Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.Semantic proximity Read ↗

Control of Her-2 tumor immunity and thyroid autoimmunity by MHC and regulatory T cells.Semantic proximity Read ↗

Autoimmunity and Cancer—Two Sides of the Same CoinSemantic proximity Read ↗

Multiple pathways to tumor immunity and concomitant autoimmunity.Semantic proximity Read ↗

Distinct genetic pattern of mouse susceptibility to thyroiditis induced by a novel thyroglobulin peptide.Semantic proximity Read ↗

Flexibility of TCR repertoire and permissiveness of HLA-DR3 molecules in experimental autoimmune thyroiditis in nonobese diabetic mice.Semantic proximity Read ↗

Graded Foxo1 activity in Treg cells differentiates tumour immunity from spontaneous autoimmunity.Semantic proximity Read ↗

Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor EfficacySemantic proximity Read ↗

A novel H2A-E+ transgenic model susceptible to human but not mouse thyroglobulin-induced autoimmune thyroiditis: identification of mouse pathogenic epitopes.Semantic proximity Read ↗

H2A- and H2E-derived CD4+CD25+ regulatory T cells: a potential role in reciprocal inhibition by class II genes in autoimmune thyroiditis.Semantic proximity Read ↗

Inhibition of the IL-17A axis Protects against Immune-related Adverse Events while Supporting Checkpoint Inhibitor Anti-tumor EfficacySemantic proximity Read ↗

Tolerance to autoimmune thyroiditis: (CD4+)CD25+ regulatory T cells influence susceptibility but do not supersede MHC class II restriction.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.